NYSE:MMS - MAXIMUS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$71.59 +0.91 (+1.29 %)
(As of 04/24/2019 08:24 AM ET)
Previous Close$70.68
Today's Range$70.72 - $72.08
52-Week Range$60.00 - $73.81
Volume285,657 shs
Average Volume333,817 shs
Market Capitalization$4.57 billion
P/E Ratio21.06
Dividend Yield1.41%
Beta0.96
MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. This segment offers program eligibility support and enrollment; application assistance and independent health plan enrollment counseling; beneficiary outreach, education, eligibility, enrollment, and renewal; document and record management; payment processing and administration; and digital eHealth and wellbeing solutions. It also provides independent disability, long-term sick, and other health assessment; occupational health clinical assessment; specialized consulting; and centralized multilingual customer contact centers and multichannel self-service options for enrollment. The company's U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; and Medicare and Medicaid appeals, and program eligibility appeals. It also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The company's Human Services segment offers national, state, provincial, and local human services agencies, as well as various BPS and related consulting services. It also provides management tools and professional consulting, program consulting, and tax credit and employer services. The company was founded in 1975 and is headquartered in Reston, Virginia.

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
CUSIP57793310
Phone703-251-8500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.39 billion
Cash Flow$4.4969 per share
Book Value$16.91 per share

Profitability

Net Income$220.75 million

Miscellaneous

Employees18,600
Market Cap$4.57 billion
Next Earnings Date5/9/2019 (Estimated)
OptionableOptionable

MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS declared a quarterly dividend on Thursday, April 11th. Shareholders of record on Wednesday, May 15th will be given a dividend of $0.25 per share on Friday, May 31st. This represents a $1.00 annualized dividend and a yield of 1.40%. The ex-dividend date of this dividend is Tuesday, May 14th. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS announced that its board has approved a stock repurchase program on Monday, June 25th 2018, which allows the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 4.9% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, February, 7th. The health services provider reported $0.86 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.06. The health services provider earned $664.60 million during the quarter, compared to analyst estimates of $672.08 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. The company's quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company posted $0.89 earnings per share. View MAXIMUS's Earnings History.

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for MAXIMUS.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS updated its FY19 earnings guidance on Thursday, February, 7th. The company provided earnings per share (EPS) guidance of $3.55 to $3.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.63. The company issued revenue guidance of $2.93 billion to $3.00 billion, compared to the consensus revenue estimate of $2.95 billion.MAXIMUS also updated its FY 2019 guidance to $3.55-3.75 EPS.

What price target have analysts set for MMS?

1 brokers have issued 12-month target prices for MAXIMUS's stock. Their forecasts range from $67.00 to $81.00. On average, they expect MAXIMUS's stock price to reach $74.00 in the next twelve months. This suggests a possible upside of 3.4% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

News coverage about MMS stock has trended somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MAXIMUS earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the company's share price in the immediate future.

Who are some of MAXIMUS's key competitors?

What other stocks do shareholders of MAXIMUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Tesla (TSLA), Bank of America (BAC), AGNC Investment (AGNC), Micron Technology (MU), NVIDIA (NVDA), QUALCOMM (QCOM), 3D Systems (DDD), Southwest Airlines (LUV), Wells Fargo & Co (WFC) and Adamis Pharmaceuticals (ADMP).

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Mondrian Investment Partners LTD (1.37%), Riverbridge Partners LLC (0.83%), Retirement Systems of Alabama (0.25%), West Coast Financial LLC (0.16%), Rowland & Co. Investment Counsel ADV (0.04%) and Liberty Capital Management Inc. (0.02%). Company insiders that own MAXIMUS stock include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

Which institutional investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, First Quadrant L P CA, Mondrian Investment Partners LTD, Strs Ohio and Verus Financial Partners Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

Which institutional investors are buying MAXIMUS stock?

MMS stock was bought by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Mercer Global Advisors Inc. ADV, 6 Meridian, West Coast Financial LLC, Meeder Asset Management Inc., We Are One Seven LLC, Rowland & Co. Investment Counsel ADV and First Citizens Bank & Trust Co.. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $71.59.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.57 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  368 (Vote Outperform)
Underperform Votes:  355 (Vote Underperform)
Total Votes:  723
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel